Technical Analysis for BPTH - Bio-Path Holdings Inc

Grade Last Price % Change Price Change
D 6.57 1.70% 0.11
BPTH closed down 0.31 percent on Monday, March 1, 2021, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical BPTH trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 1.70%
Narrow Range Bar Range Contraction 1.70%
Wide Bands Range Expansion 1.70%
Oversold Stochastic Weakness 1.70%
Fell Below 20 DMA Bearish 1.39%
1,2,3 Pullback Bullish Bullish Swing Setup 1.39%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.39%
Narrow Range Bar Range Contraction 1.39%
NR7 Range Contraction 1.39%
Wide Bands Range Expansion 1.39%
Older End-of-Day Signals for BPTH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low 10 minutes ago
Up 3% about 1 hour ago
Up 2% about 1 hour ago
Up 1% about 1 hour ago
60 Minute Opening Range Breakdown about 24 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Acid Solid Tumors Lymphoma Breast Cancer Treatment Of Breast Cancer Therapeutic Product Cell Biology Therapeutic Products Oncogenes Apoptosis Blood Cancers Breast Cancers Human Body

Is BPTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.34
52 Week Low 2.9203
Average Volume 2,440,302
200-Day Moving Average 4.64
50-Day Moving Average 5.05
20-Day Moving Average 6.69
10-Day Moving Average 7.08
Average True Range 1.23
ADX 48.04
+DI 55.41
-DI 19.56
Chandelier Exit (Long, 3 ATRs ) 20.65
Chandelier Exit (Short, 3 ATRs ) 7.65
Upper Bollinger Band 10.46
Lower Bollinger Band 2.93
Percent B (%b) 0.47
BandWidth 112.56
MACD Line 0.55
MACD Signal Line 0.77
MACD Histogram -0.2201
Fundamentals Value
Market Cap 29.34 Million
Num Shares 4.54 Million
EPS -6.19
Price-to-Earnings (P/E) Ratio -1.04
Price-to-Sales 0.00
Price-to-Book 1.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.98
Resistance 3 (R3) 7.02 6.89 6.90
Resistance 2 (R2) 6.89 6.75 6.87 6.87
Resistance 1 (R1) 6.67 6.67 6.61 6.63 6.84
Pivot Point 6.54 6.54 6.50 6.52 6.54
Support 1 (S1) 6.32 6.40 6.26 6.29 6.08
Support 2 (S2) 6.19 6.32 6.17 6.05
Support 3 (S3) 5.97 6.19 6.02
Support 4 (S4) 5.94